日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Population pharmacokinetics of molnupiravir in adults with COVID-19: Lack of clinically important exposure variation across individuals

成人 COVID-19 患者中莫努匹拉韦的群体药代动力学：个体间缺乏具有临床意义的暴露量差异

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13031
Bihorel, Sébastien; Cao, Youfang; Chawla, Akshita; Birger, Ruthie; Maas, Brian M; Gao, Wei; Roepcke, Stefan; Sardella, Susanne; Humphrey, Rebecca; Kondragunta, Sindhuri; Jayaraman, Bhuvana; Martinho, Monika; Painter, Wendy; Painter, George; Holman, Wayne; De Anda, Carisa; Brown, Michelle L; Johnson, Matthew G; Paschke, Amanda; Rizk, Matthew L; Stone, Julie A
发表日期：2023
文献求助 收藏

Phase 1b/3 Pharmacokinetics and Safety Study of Intravenous Posaconazole in Adult Asian Participants at High Risk for Invasive Fungal Infections

一项针对高危侵袭性真菌感染亚洲成年受试者的静脉注射泊沙康唑的 1b/3 期药代动力学和安全性研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-021-02012-1
Wu, Depei; Mi, Yingchang; Weng, Jianyu; Zhuang, Junling; Ke, Xiaoyan; Wang, Chun; Liu, Kaiyan; Martinho, Monika; Winchell, Gregory A; Zang, Yanqiao; Xu, Lianzhe
炎症/感染
微生物学
发表日期：2022
文献求助 收藏

Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers

在健康志愿者中，丙型肝炎病毒抑制剂艾尔巴韦和格拉佐普韦与HIV蛋白酶抑制剂利托那韦、阿扎那韦、洛匹那韦和达芦那韦之间的药代动力学相互作用

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02142-18
Feng, Hwa-Ping; Caro, Luzelena; Fandozzi, Christine; Chu, Xiaoyan; Guo, Zifang; Talaty, Jennifer; Panebianco, Deborah; Dunnington, Katherine; Du, Lihong; Hanley, William D; Fraser, Iain P; Mitselos, Anna; Denef, Jean-Francois; De Lepeleire, Inge; de Hoon, Jan N; Vandermeulen, Corinne; Marshall, William L; Jumes, Patricia; Huang, Xiaobi; Martinho, Monika; Valesky, Robert; Butterton, Joan R; Iwamoto, Marian; Yeh, Wendy W
HIV
肝炎
微生物学
发表日期：2019
文献求助 收藏

Effect of tildrakizumab (MK-3222), a high affinity, selective anti-IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis.

tildrakizumab (MK-3222) 是一种高亲和力、选择性抗 IL23p19 单克隆抗体，对中重度银屑病患者细胞色素 P450 代谢的影响

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.13670
Khalilieh Sauzanne, Hussain Azher, Montgomery Diana, Levine Vanessa, Shaw Peter M, Bodrug Inga, Mekokishvili Lally, Bailey-Smith Candice, Glasgow Xiaoli S, Cheng Amy, Martinho Monika, Iwamoto Marian
代谢
细胞生物学
银屑病
发表日期：2018
文献求助 收藏

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy

在健康受试者和接受稳定阿片类激动剂治疗的受试者中，艾尔巴韦或格拉佐普韦与丁丙诺啡/纳洛酮之间未观察到药代动力学相互作用。

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.12565
Feng, Hwa-Ping; Guo, Zifang; Caro, Luzelena; Marshall, William L; Liu, Fang; Panebianco, Deborah; Vaddady, Pavan; Barbour, April; Reitmann, Christina; Jumes, Patricia; Gilmartin, Jocelyn; Wolford, Dennis; Valesky, Robert; Martinho, Monika; Butterton, Joan R; Iwamoto, Marian; Fraser, Iain; Webster, Lynn; Yeh, Wendy W
发表日期：2018
文献求助 收藏

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy

在接受维持性阿片类激动剂治疗的受试者中，艾尔巴韦或格拉佐普韦与美沙酮之间未观察到药代动力学相互作用。

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.12564
Feng, Hwa-Ping; Guo, Zifang; Caro, Luzelena; Marshall, William L; Liu, Fang; Panebianco, Deborah; Vaddady, Pavan; Reitmann, Christina; Jumes, Patricia; Wolford, Dennis; Fraser, Iain; Valesky, Robert; Martinho, Monika; Butterton, Joan R; Iwamoto, Marian; Webster, Lynn; Yeh, Wendy W
发表日期：2018
文献求助 收藏

Posaconazole plasma concentrations in juvenile patients with invasive fungal infection

泊沙康唑血浆浓度在患有侵袭性真菌感染的青少年患者中的变化

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00454-06
Krishna, Gopal; Sansone-Parsons, Angela; Martinho, Monika; Kantesaria, Bhavna; Pedicone, Lisa
炎症/感染
微生物学
发表日期：2007
文献求助 收藏